Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases.

Saved in:
Bibliographic Details
Title: Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases.
Authors: Challa AP; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States., Zaleski NM; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States., Jerome RN; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States., Lavieri RR; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States., Shirey-Rice JK; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States., Barnado A; Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt Medical Center, Nashville, TN, United States., Lindsell CJ; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, United States., Aronoff DM; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States., Crofford LJ; Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt Medical Center, Nashville, TN, United States., Harris RC; Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States., Alp Ikizler T; Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States., Mayer IA; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States., Holroyd KJ; Center for Technology Transfer and Commercialization, Vanderbilt University, Nashville, TN, United States., Pulley JM; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.
Source: Frontiers in genetics [Front Genet] 2021 Jul 28; Vol. 12, pp. 707836. Date of Electronic Publication: 2021 Jul 28 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-8021
DOI:10.3389/fgene.2021.707836